PT2010538E - Processo para a preparação de éster 2-[4-(4-fluoro-2- metil-1h-indol-5-iloxi)-5-metilpirrolo[2,1-f][1,2,4]- triazin-6-iloxi]-1 -metiletílico do ácido [(1r), 2s]-2- aminopropiónico - Google Patents

Processo para a preparação de éster 2-[4-(4-fluoro-2- metil-1h-indol-5-iloxi)-5-metilpirrolo[2,1-f][1,2,4]- triazin-6-iloxi]-1 -metiletílico do ácido [(1r), 2s]-2- aminopropiónico

Info

Publication number
PT2010538E
PT2010538E PT77608727T PT07760872T PT2010538E PT 2010538 E PT2010538 E PT 2010538E PT 77608727 T PT77608727 T PT 77608727T PT 07760872 T PT07760872 T PT 07760872T PT 2010538 E PT2010538 E PT 2010538E
Authority
PT
Portugal
Prior art keywords
uml
yloxy
triazin
indol
fluoro
Prior art date
Application number
PT77608727T
Other languages
English (en)
Inventor
Jale Muslehiddinoglu
Gerard A Crispino
Mourad Hamedi
Thomas L Laporte
John E Thornton
Jaan A Pesti
Zhongmin Xu
Paul C Lobben
David K Leahy
Chiajen Lai
Lori Ann Gler
Robert P Rdia
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38357966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2010538(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PT2010538E publication Critical patent/PT2010538E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT77608727T 2006-04-21 2007-04-19 Processo para a preparação de éster 2-[4-(4-fluoro-2- metil-1h-indol-5-iloxi)-5-metilpirrolo[2,1-f][1,2,4]- triazin-6-iloxi]-1 -metiletílico do ácido [(1r), 2s]-2- aminopropiónico PT2010538E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74530006P 2006-04-21 2006-04-21

Publications (1)

Publication Number Publication Date
PT2010538E true PT2010538E (pt) 2013-02-22

Family

ID=38357966

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77608727T PT2010538E (pt) 2006-04-21 2007-04-19 Processo para a preparação de éster 2-[4-(4-fluoro-2- metil-1h-indol-5-iloxi)-5-metilpirrolo[2,1-f][1,2,4]- triazin-6-iloxi]-1 -metiletílico do ácido [(1r), 2s]-2- aminopropiónico

Country Status (23)

Country Link
US (1) US7671199B2 (pt)
EP (1) EP2010538B1 (pt)
JP (1) JP5203353B2 (pt)
KR (1) KR101423789B1 (pt)
CN (1) CN101472927B (pt)
AR (1) AR060622A1 (pt)
AU (1) AU2007240453B2 (pt)
BR (1) BRPI0710691A2 (pt)
CA (1) CA2650059A1 (pt)
CL (2) CL2007001141A1 (pt)
DK (1) DK2010538T3 (pt)
EA (1) EA019693B1 (pt)
ES (1) ES2399379T3 (pt)
HR (1) HRP20130099T1 (pt)
IL (1) IL194715A (pt)
MX (1) MX2008013232A (pt)
NO (1) NO20084326L (pt)
PE (1) PE20080193A1 (pt)
PL (1) PL2010538T3 (pt)
PT (1) PT2010538E (pt)
SI (1) SI2010538T1 (pt)
TW (1) TWI378100B (pt)
WO (1) WO2007124332A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007038648A1 (en) * 2005-09-27 2007-04-05 Bristol-Myers Squibb Company Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
US20120135875A1 (en) * 2008-02-29 2012-05-31 Bristol-Myers Squibb Company Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
EP2376491B1 (en) 2008-12-19 2015-03-04 Cephalon, Inc. Pyrrolotriazines as alk and jak2 inhibitors
US11860139B2 (en) 2018-10-08 2024-01-02 Applied Photophysics Limited System and method for analysing the composition of a quenched flow reaction liquid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982265B1 (en) * 1999-05-21 2006-01-03 Bristol Myers Squibb Company Pyrrolotriazine inhibitors of kinases
TWI329112B (en) * 2002-07-19 2010-08-21 Bristol Myers Squibb Co Novel inhibitors of kinases
TWI272271B (en) * 2002-07-19 2007-02-01 Bristol Myers Squibb Co Process for preparing certain pyrrolotriazine compounds
US7432373B2 (en) * 2004-06-28 2008-10-07 Bristol-Meyers Squibb Company Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
US7173031B2 (en) * 2004-06-28 2007-02-06 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
WO2006130657A2 (en) * 2005-05-31 2006-12-07 Bristol-Myers Squibb Company Stereoselective reduction process for the preparation of pyrrolotriazine compounds
WO2007038648A1 (en) * 2005-09-27 2007-04-05 Bristol-Myers Squibb Company Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester

Also Published As

Publication number Publication date
HRP20130099T1 (hr) 2013-03-31
IL194715A (en) 2013-10-31
AU2007240453A1 (en) 2007-11-01
ES2399379T3 (es) 2013-04-01
CN101472927A (zh) 2009-07-01
MX2008013232A (es) 2008-10-21
AR060622A1 (es) 2008-07-02
JP5203353B2 (ja) 2013-06-05
US20070249610A1 (en) 2007-10-25
JP2009534413A (ja) 2009-09-24
KR20090008246A (ko) 2009-01-21
EA019693B1 (ru) 2014-05-30
CL2010000554A1 (es) 2010-10-15
CN101472927B (zh) 2012-07-04
US7671199B2 (en) 2010-03-02
CA2650059A1 (en) 2007-11-01
DK2010538T3 (da) 2013-03-18
TW200808799A (en) 2008-02-16
BRPI0710691A2 (pt) 2011-08-23
NO20084326L (no) 2008-11-18
EP2010538B1 (en) 2012-12-05
PE20080193A1 (es) 2008-03-10
EP2010538A1 (en) 2009-01-07
WO2007124332A1 (en) 2007-11-01
TWI378100B (en) 2012-12-01
CL2007001141A1 (es) 2008-01-18
SI2010538T1 (sl) 2013-06-28
PL2010538T3 (pl) 2013-04-30
KR101423789B1 (ko) 2014-07-30
AU2007240453B2 (en) 2012-04-12
EA200802171A1 (ru) 2009-08-28

Similar Documents

Publication Publication Date Title
DK3872058T3 (en) Process for the preparation of 2,3,3,3 tetrahydrofluoropropene
PL1993985T3 (pl) Sposób wytwarzania 1,2-propanodiolu
TWI371442B (en) Process for producing carboxylic acid
EP1911738A4 (en) PHENOXYALKANSÄUREVERBINDUNG
EP1916234A4 (en) Cyclopropanecarboxylate CONNECTION
TWI349660B (en) Process for producing acetic acid
EP1672067A4 (en) PROCESS FOR PRODUCING NON-AMINE ORGANIC ACID
EP2049463A4 (en) PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE CYCLOPROPYLAMINES
EP1888728A4 (en) Fatty acid analogues, D.H. DHA DERIVATIVES FOR USE AS A MEDICAMENT
IL197014A0 (en) Process for the manufacture of snac (salcaprozate sodium)
EP1950197A4 (en) PROCESS FOR PREPARING PENTAERYTHRITMERCAPTOCARBOXYLIC ACID ESTERS, PENTAERYTHRITMERCAPTOCARBOXYLIC ACID RECEIVED THEREOF AND USE THEREOF
TWI365182B (en) Process for producing acetic acid
IL183591A0 (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
ZA200804171B (en) Chemical process for the preparation of an amidophenoxybenzoic acid compound
IL180311A0 (en) Process for the preparation of 4,4-difluoro-3-oxobutanoic acid esters
HRP20181437T1 (hr) Postupak proizvodnje (3s,3s') 4,4' disulfanedilbis (3-aminobutan-1-sulfonske kiseline)
EP1950191A4 (en) PROCESS FOR PRODUCING 3,3,3-TRIFLUOROPROPIONIC ACID
EP1747212A4 (en) PROCESS FOR PRODUCING N-SULFINATED AMINO ACID DERIVATIVES
IL192190A0 (en) Process for the preparation of pharmaceutical salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid
EP1927586A4 (en) PROCESS FOR PRODUCTION OF 5-AMINOLEVULINIC ACID CHLORHYDRATE
PL2102174T3 (pl) Sposób wytwarzania pochodnych podstawionych cyjanofenoksy-pirymidynyloksyfenyloakrylanów
PT2010538E (pt) Processo para a preparação de éster 2-[4-(4-fluoro-2- metil-1h-indol-5-iloxi)-5-metilpirrolo[2,1-f][1,2,4]- triazin-6-iloxi]-1 -metiletílico do ácido [(1r), 2s]-2- aminopropiónico
PL1700855T3 (pl) Sposób wytwarzania tazarotenu
EP2025663A4 (en) NOVEL CARBOXYLIC ACID COMPOUND, ITS APPLICATION AND METHOD OF PRODUCTION
ZA200409433B (en) Process for the preparation of carboxylic acid esters.